Skip to Content
You are currently on the new version of our website. Access the old version .

Most Cited

  • Feature Paper
  • Review
  • Open Access
112 Citations
22,286 Views
32 Pages

Role of Oxidative Stress in Liver Disorders

  • Laura Conde de la Rosa,
  • Leire Goicoechea,
  • Sandra Torres,
  • Carmen Garcia-Ruiz and
  • José C. Fernandez-Checa

14 October 2022

Oxygen is vital for life as it is required for many different enzymatic reactions involved in intermediate metabolism and xenobiotic biotransformation. Moreover, oxygen consumption in the electron transport chain of mitochondria is used to drive the...

  • Review
  • Open Access
88 Citations
21,543 Views
47 Pages

Oxidative Stress in Non-Alcoholic Fatty Liver Disease

  • Carlo Smirne,
  • Eleonora Croce,
  • Davide Di Benedetto,
  • Vincenzo Cantaluppi and ,
  • Cristoforo Comi,
  • Pier Paolo Sainaghi,
  • Rosalba Minisini,
  • Elena Grossini and
  • Mario Pirisi
  • + 4 authors+ 0 author

1 February 2022

Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple factors, which may partly explain why it still remains an orphan of adequate therapies. This review highlights the interaction between oxidative stress (OS) and dis...

  • Article
  • Open Access
62 Citations
18,891 Views
19 Pages

Statistical Machine Learning Approaches to Liver Disease Prediction

  • Fahad Mostafa,
  • Easin Hasan,
  • Morgan Williamson and
  • Hafiz Khan

1 December 2021

Medical diagnoses have important implications for improving patient care, research, and policy. For a medical diagnosis, health professionals use different kinds of pathological methods to make decisions on medical reports in terms of the patients&rs...

  • Review
  • Open Access
55 Citations
7,670 Views
15 Pages

Perspective on Quantitative Structure–Toxicity Relationship (QSTR) Models to Predict Hepatic Biotransformation of Xenobiotics

  • Mansi Rai,
  • Namuna Paudel,
  • Mesevilhou Sakhrie,
  • Donato Gemmati and ,
  • Inshad Ali Khan,
  • Veronica Tisato,
  • Anurag Kanase,
  • Armin Schulz and
  • Ajay Vikram Singh
  • + 4 authors+ 0 author

30 August 2023

Biotransformation refers to the metabolic conversion of endogenous and xenobiotic chemicals into more hydrophilic substances. Xenobiotic biotransformation is accomplished by a restricted number of enzymes with broad substrate specificities. The biotr...

  • Review
  • Open Access
43 Citations
51,553 Views
24 Pages

The Space of Disse: The Liver Hub in Health and Disease

  • Carlos Sanz-García,
  • Anabel Fernández-Iglesias,
  • Jordi Gracia-Sancho,
  • Luis Alfonso Arráez-Aybar and ,
  • Yulia A. Nevzorova and
  • Francisco Javier Cubero
  • + 1 author+ 0 author

3 February 2021

Since it was first described by the German anatomist and histologist, Joseph Hugo Vincenz Disse, the structure and functions of the space of Disse, a thin perisinusoidal area between the endothelial cells and hepatocytes filled with blood plasma, hav...

  • Article
  • Open Access
38 Citations
4,540 Views
9 Pages

Perfluoroalkyl Carboxylic Acids Interact with the Human Bile Acid Transporter NTCP

  • Melissa J. Ruggiero,
  • Haley Miller,
  • Jessica Y. Idowu,
  • Jeremiah D. Zitzow and ,
  • Shu-Ching Chang and
  • Bruno Hagenbuch
  • + 1 author+ 0 author

18 October 2021

Na+/taurocholate cotransporting polypeptide (NTCP) is important for the enterohepatic circulation of bile acids, which has been suggested to contribute to the long serum elimination half-lives of perfluoroalkyl substances in humans. We demonstrated t...

  • Review
  • Open Access
34 Citations
7,975 Views
13 Pages

10 April 2023

Mitochondria are critical organelles responsible for the maintenance of cellular energy homeostasis. Thus, their dysfunction can have severe consequences in cells responsible for energy-intensive metabolic function, such as hepatocytes. Extensive res...

(This article belongs to the Special Issue Recent Advances in Acetaminophen Hepatotoxicity)
  • Review
  • Open Access
32 Citations
42,553 Views
53 Pages

25 June 2025

Liver cirrhosis poses major challenges for both individual health and global healthcare systems. Recent studies have challenged the traditional and predictable linear course of cirrhosis, demonstrating marked heterogeneity in the patterns of the firs...

  • Review
  • Open Access
32 Citations
6,996 Views
14 Pages

Mitochondrial Dynamics in Drug-Induced Liver Injury

  • Anup Ramachandran,
  • David S. Umbaugh and
  • Hartmut Jaeschke

23 June 2021

Mitochondria have been studied for decades from the standpoint of metabolism and ATP generation. However, in recent years mitochondrial dynamics and its influence on bioenergetics and cellular homeostasis is also being appreciated. Mitochondria under...

  • Review
  • Open Access
31 Citations
12,995 Views
29 Pages

An Updated Review on Advances in Hydrogel-Based Nanoparticles for Liver Cancer Treatment

  • Bahareh Farasati Far,
  • Ali Attaripour Isfahani,
  • Elnaz Nasiriyan,
  • Ali Pourmolaei and ,
  • Golnaz Mahmoudvand,
  • Arian Karimi Rouzbahani,
  • Mohammed Namiq Amin and
  • Mohammad Reza Naimi-Jamal
  • + 3 authors+ 0 author

27 March 2023

More than 90% of all liver malignancies are hepatocellular carcinomas (HCCs), for which chemotherapy and immunotherapy are the ideal therapeutic choices. Hepatocellular carcinoma is descended from other liver diseases, such as viral hepatitis, alcoho...

  • Review
  • Open Access
30 Citations
12,878 Views
10 Pages

The Epidemiology of Chronic Hepatitis C: Where We Are Now

  • Cristina Stasi,
  • Caterina Milli,
  • Fabio Voller and
  • Caterina Silvestri

30 March 2024

One of the main objectives of the World Health Organization is the eradication of viral hepatitis by 2030 by identifying subjects before disease progression. In 2019, only 21% of the 58 million people chronically infected with hepatitis C virus (HCV)...

  • Review
  • Open Access
29 Citations
15,143 Views
33 Pages

Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications

  • Farah Abdelhameed,
  • Attia Mustafa,
  • Chris Kite,
  • Lukasz Lagojda and ,
  • Alexander Dallaway,
  • Nwe Ni Than,
  • Eva Kassi,
  • Ioannis Kyrou and
  • Harpal S. Randeva
  • + 4 authors+ 0 author

4 March 2025

Non-alcoholic fatty liver disease (NAFLD), recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common cause of chronic liver disease worldwide. Characterized by excessive hepatic fat accumulation, this...

  • Review
  • Open Access
27 Citations
17,495 Views
21 Pages

Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review

  • Karima Begriche,
  • Clémence Penhoat,
  • Pénélope Bernabeu-Gentey,
  • Julie Massart and
  • Bernard Fromenty

12 January 2023

The epidemic of obesity, type 2 diabetes and nonalcoholic liver disease (NAFLD) favors drug consumption, which augments the risk of adverse events including liver injury. For more than 30 years, a series of experimental and clinical investigations re...

(This article belongs to the Special Issue Recent Advances in Acetaminophen Hepatotoxicity)
  • Review
  • Open Access
24 Citations
28,753 Views
19 Pages

6 September 2022

Background: Spontaneous bacterial peritonitis (SBP) is defined as a bacterial infection of the ascitic fluid without a surgically treatable intra-abdominal infection source. SBP is a common, severe complication in cirrhosis patients with ascites, and...

(This article belongs to the Topic Liver Fibrosis and Cirrhosis)
  • Review
  • Open Access
23 Citations
50,965 Views
25 Pages

Herbal- and Dietary-Supplement-Induced Liver Injury: A Review of the Recent Literature

  • Palak A. Patel-Rodrigues,
  • Lindsey Cundra,
  • Dalal Alhaqqan,
  • Daniel T. Gildea and ,
  • Stephanie M. Woo and
  • James H. Lewis
  • + 1 author+ 0 author

13 February 2024

Herbal-induced liver injury (HILI) continues to increase in prevalence each year due to the ongoing popularity of herbal supplements and complementary and alternative medicines. A detailed literature review of case reports and clinical studies publis...

  • Feature Paper
  • Review
  • Open Access
20 Citations
7,944 Views
15 Pages

One Carbon Metabolism and S-Adenosylmethionine in Non-Alcoholic Fatty Liver Disease Pathogenesis and Subtypes

  • David Fernández-Ramos,
  • Fernando Lopitz-Otsoa,
  • Oscar Millet,
  • Cristina Alonso and ,
  • Shelly C. Lu and
  • José M. Mato
  • + 1 author+ 0 author

4 October 2022

One carbon metabolism (1CM) can be defined as the transfer of a carbon unit from one metabolite to another and its replenishment by different sources of labile methyl-group nutrients: primarily choline, methionine, betaine, and serine. This flow of c...

  • Review
  • Open Access
18 Citations
29,244 Views
19 Pages

Hidden Dangers: Herbal and Dietary Supplement Induced Hepatotoxicity

  • Jonathan Kwong-Shing Lin and
  • Shannan R. Tujios

31 October 2023

Herbal and dietary supplements represent a multi-billion-dollar industry reportedly used by over half of American adults. However, these products are not regulated by the Federal Drug Agency and contain a wide range of contaminants, leading to over 5...

  • Review
  • Open Access
17 Citations
19,363 Views
20 Pages

A Comprehensive Review on the Use of Herbal Dietary Supplements in the USA, Reasons for Their Use, and Review of Potential Hepatotoxicity

  • Adnan Khan,
  • Kashyap Chauhan,
  • Heather Ross,
  • Natalia Salinas Parra and ,
  • John Magagna,
  • Makala Wang,
  • Patrick Zhu,
  • Ryan Erwin and
  • Dina Halegoua-DeMarzio
  • + 4 authors+ 0 author

2 August 2022

Herbal and dietary supplement (HDS) use has grown exponentially in the United States. Unfortunately, the incidence of HDS-related liver injury has proportionally increased. Despite the potential for certain HDSs to cause clinically significant liver...

  • Review
  • Open Access
17 Citations
10,207 Views
24 Pages

13 September 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses metabolic dysfunction-associated fatty liver (MASL) and metabolic dysfunction-associated steatohepatitis (MASH), with MASH posing a risk of progression to cirrhosis and hepa...

  • Review
  • Open Access
17 Citations
14,539 Views
40 Pages

Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy

  • Bahareh Farasati Far,
  • Dorsa Rabie,
  • Parisa Hemati,
  • Parastoo Fooladpanjeh and ,
  • Neda Faal Hamedanchi,
  • Nima Broomand Lomer,
  • Arian Karimi Rouzbahani and
  • Mohammad Reza Naimi-Jamal
  • + 3 authors+ 0 author

13 March 2023

With an expected incidence of more than 1 million cases by 2025, liver cancer remains a problem for world health. With over 90% of cases, hepatocellular carcinoma (HCC) is the most prevalent kind of liver cancer. In this review, we presented the rang...

  • Article
  • Open Access
16 Citations
4,159 Views
8 Pages

Seroprevalence of Hepatitis E Virus Antibodies (IgG) in the Community of Rawalpindi

  • Muhammad Awais Farooqi,
  • Ali Ahsan,
  • Shazia Yousuf,
  • Noman Shakoor and
  • Hafiz Muhammad Umer Farooqi

27 July 2022

Knowledge regarding the prevalence of the hepatitis E virus (HEV) in the general population can indicate public health and personal hygiene practices in a community. HEV spreads through the fecal-oral route and contaminates drinking water through sew...

  • Review
  • Open Access
16 Citations
9,585 Views
31 Pages

5 September 2023

Imaging-based body composition analysis can quantify visceral fat, which is an important feature of lean non-alcoholic fatty liver disease (NAFLD) patients. This review assesses current evidence of the relationship between NAFLD, particularly hepatic...

  • Review
  • Open Access
16 Citations
13,917 Views
21 Pages

28 October 2023

Metabolic dysfunction associated fatty liver disease (MAFLD) has been recently recognized as a new global chronic liver disease entity with non-alcoholic fatty liver disease (NAFLD) associated with overweight/obesity or type 2 diabetes mellitus (T2DM...

  • Review
  • Open Access
15 Citations
4,242 Views
8 Pages

1 December 2021

Circulating biomarkers of drug-induced liver injury (DILI) have been a focus of research in hepatology over the last decade, and several novel DILI biomarkers that hold promise for certain applications have been identified. For example, glutamate deh...

  • Article
  • Open Access
15 Citations
5,215 Views
12 Pages

The Role of Cytochrome P450 3A4-Mediated Metabolism in Sorafenib and Lapatinib Hepatotoxicity

  • Mitchell R. McGill,
  • Yihong Kaufmann,
  • Francesca V. LoBianco,
  • Mary A. Schleiff and ,
  • Nukhet Aykin-Burns and
  • Grover P. Miller
  • + 1 author+ 0 author

19 June 2023

Tyrosine kinase inhibitors (TKIs) are increasingly popular drugs used to treat more than a dozen different diseases including some forms of cancer. Despite having fewer adverse effects than traditional chemotherapies, they are not without risks. Live...

  • Review
  • Open Access
15 Citations
10,673 Views
16 Pages

23 September 2024

Intestinal mucus serves as the first line barrier within the mucosa to protect against microbiota attack due to its water-repellent properties, which are the result of the high abundance of phosphatidylcholine bound to mucins. A deficiency of mucus p...

  • Review
  • Open Access
15 Citations
15,314 Views
20 Pages

Deciphering the Gut–Liver Axis: A Comprehensive Scientific Review of Non-Alcoholic Fatty Liver Disease

  • Samradhi Singh,
  • Mona Kriti,
  • Roberto Catanzaro,
  • Francesco Marotta and ,
  • Mustafa Malvi,
  • Ajay Jain,
  • Vinod Verma,
  • Ravinder Nagpal,
  • Rajnarayan Tiwari and
  • Manoj Kumar
  • + 5 authors+ 0 author

12 September 2024

Non-alcoholic fatty liver disease (NAFLD) has emerged as a significant global health issue. The condition is closely linked to metabolic dysfunctions such as obesity and type 2 diabetes. The gut–liver axis, a bidirectional communication pathway...

  • Review
  • Open Access
15 Citations
9,879 Views
19 Pages

Role of Mitochondrial Iron Uptake in Acetaminophen Hepatotoxicity

  • Jiangting Hu,
  • Anna-Liisa Nieminen,
  • Zhi Zhong and
  • John J. Lemasters

30 July 2024

Overdose of acetaminophen (APAP) produces fulminant hepatic necrosis. The underlying mechanism of APAP hepatotoxicity involves mitochondrial dysfunction, including mitochondrial oxidant stress and the onset of mitochondrial permeability transition (M...

(This article belongs to the Special Issue Recent Advances in Acetaminophen Hepatotoxicity)
  • Review
  • Open Access
15 Citations
7,027 Views
29 Pages

The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease

  • Carlo Acierno,
  • Riccardo Nevola,
  • Luca Rinaldi,
  • Ferdinando Carlo Sasso and ,
  • Luigi Elio Adinolfi and
  • Alfredo Caturano
  • + 1 author+ 0 author

10 April 2025

Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multifactorial condition linked to liver injury, insulin resistance, and disrupted gut–liver interactions. A key aspect of MASLD pathogenesis is the dysfunction of inte...

  • Review
  • Open Access
15 Citations
9,218 Views
10 Pages

9 June 2023

Liver regeneration is a compensatory response to tissue injury and loss. It is known that liver regeneration plays a crucial role in recovery following acetaminophen (APAP)-induced hepatotoxicity, which is the major cause of acute liver failure (ALF)...

(This article belongs to the Special Issue Recent Advances in Acetaminophen Hepatotoxicity)
  • Feature Paper
  • Review
  • Open Access
15 Citations
16,730 Views
28 Pages

27 October 2023

Acetaminophen (APAP) is a widely used drug, but overdose can cause severe acute liver injury. The first reports of APAP hepatotoxicity in humans were published in 1966, shortly after the development of alanine aminotransferase (ALT) and aspartate ami...

(This article belongs to the Special Issue Recent Advances in Acetaminophen Hepatotoxicity)
  • Review
  • Open Access
14 Citations
7,505 Views
12 Pages

A Comprehensive Review on the Risk of Metabolic Syndrome and Cardiovascular Disease after Liver Transplantation

  • Kashyap Chauhan,
  • Adnan Khan,
  • Salil Chowdhury,
  • Heather M. Ross and ,
  • Natalia Salinas Parra and
  • Dina Halegoua-DeMarzio
  • + 1 author+ 0 author

29 April 2022

Survival rates after liver transplantation have increased dramatically over the past 20 years. Cardiovascular disease is the most common extra-hepatic cause of mortality in the long-term post liver transplant. This is intimately linked with both the...

  • Review
  • Open Access
13 Citations
35,629 Views
29 Pages

Principles of Nutritional Management in Patients with Liver Dysfunction—A Narrative Review

  • Essam Mohamed Elsebaie,
  • Alyaa Nasr Abdel-Fattah,
  • Nagwa Awad Bakr,
  • Kadry Mohamed Attalah and
  • Abdel-Hady Ahmed Aweas

4 April 2023

According to studies, the liver’s ability to perform its physiological functions in the body determines the diet of patients with liver diseases. Malnutrition results from the liver’s inability to metabolize nutrients as a result of chron...

  • Opinion
  • Open Access
13 Citations
6,347 Views
7 Pages

3 August 2022

Microbiome-derived short chain fatty acids (SCFAs: acetate, propionate, and butyrate) and bile acids (BAs: primary BAs and secondary BAs) widely influence liver metabolic inflammation, immune responses, and carcinogenesis. In recent literature, the r...

  • Article
  • Open Access
12 Citations
4,862 Views
12 Pages

Preventive Effect of Gamma-Oryzanol on Physiopathological Process Related to Nonalcoholic Fatty Liver Disease in Animals Submitted to High Sugar/Fat Diet

  • Fabiane Valentini Francisqueti-Ferron,
  • Janaina Paixão das Chagas Silva,
  • Jéssica Leite Garcia,
  • Artur Junio Togneri Ferron and ,
  • Hugo Tadashi Kano,
  • Carol Cristina Vágula de Almeida Silva,
  • Mariane Róvero Costa,
  • Gisele Alborghetti Nai,
  • Fernando Moreto and
  • Camila Renata Corrêa
  • + 5 authors+ 0 author

10 August 2022

Nonalcoholic fatty liver disease (NAFLD) is the main cause of liver disease. The physiopathological processes involved in the disease are metabolic syndrome (MetS) components (central obesity, dyslipidemia, insulin resistance/type 2 diabetes, hyperte...

  • Review
  • Open Access
12 Citations
8,225 Views
58 Pages

Immune Checkpoints and the Immunology of Liver Fibrosis

  • Ioannis Tsomidis,
  • Argyro Voumvouraki and
  • Elias Kouroumalis

27 January 2025

Liver fibrosis is a very complicated dynamic process where several immune cells are involved. Both innate and adaptive immunity are implicated, and their interplay is always present. Multi-directional interactions between liver macrophages, hepatic s...

(This article belongs to the Special Issue Liver Fibrosis: Mechanisms, Targets, Assessment and Treatment)
  • Review
  • Open Access
12 Citations
19,723 Views
17 Pages

23 January 2025

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the novel terminology encompassing liver disease associated with metabolic dysfunction, replacing the previous terminology of non-alcoholic fatty liver disease (NAFLD). This disease...

  • Review
  • Open Access
12 Citations
6,797 Views
40 Pages

27 May 2025

Bisphenol analogs and their derivatives have been identified in human tissue and our living environment. There are major concerns over exposure to bisphenol analogs, especially the low-dose- and mixture-related toxicities, as they are considered pote...

  • Review
  • Open Access
12 Citations
12,649 Views
22 Pages

Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease

  • Divyavani Gowda,
  • Chandra Shekhar,
  • Siddabasave Gowda B. Gowda,
  • Yifan Chen and
  • Shu-Ping Hui

23 November 2023

Non-alcoholic fatty liver disease (NAFLD), a complex liver disorder that can result in non-alcoholic steatohepatitis, cirrhosis, and liver cancer, is the accumulation of fat in the liver seen in people due to metabolic dysfunction. The pathophysiolog...

  • Review
  • Open Access
12 Citations
11,654 Views
15 Pages

9 January 2024

Artificial Intelligence (AI) can be a useful tool in the management of disease processes such as hepatocellular carcinoma (HCC) as treatment decisions are often complex and multifaceted. AI applications in medicine are expanding with the ongoing adva...

  • Review
  • Open Access
11 Citations
14,614 Views
33 Pages

9 September 2021

Antifibrotic therapies for the treatment of liver fibrosis represent an unconquered area of drug development. The significant involvement of the gut microbiota as a driving force in a multitude of liver disease, be it pathogenesis or fibrotic progres...

  • Article
  • Open Access
11 Citations
11,490 Views
19 Pages

Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)

  • Adnan Khan,
  • Heather M. Ross,
  • Natalia Salinas Parra,
  • Sarah L. Chen and ,
  • Kashyap Chauhan,
  • Makala Wang,
  • Brian Yan,
  • John Magagna,
  • Jake Beiriger and
  • Dina Halegoua-DeMarzio
  • + 7 authors+ 2 authors

9 October 2022

Non-alcoholic fatty liver disease (NAFLD) is a serious clinicopathological condition that is recognized as the most frequent chronic liver disease, affecting 14–30% of the world’s population. The prevalence of NAFLD has rapidly grown and...

  • Article
  • Open Access
11 Citations
5,492 Views
13 Pages

Effect of Bergamot Leaves (Citrus bergamia) in the Crosstalk between Adipose Tissue and Liver of Diet-Induced Obese Rats

  • Juliana Silva Siqueira,
  • Erika Tiemi Nakandakare-Maia,
  • Taynara Aparecida Vieira,
  • Thiago Luiz Novaga Palacio and ,
  • Núbia Alves Grandini,
  • Matheus Antônio Filiol Belin,
  • Gisele Alborghetti Nai,
  • Fernando Moreto,
  • Alessandra Altomare and
  • Camila Renata Correa
  • + 8 authors+ 3 authors

11 May 2023

The excessive consumption of diets rich in sugar and fat is associated with metabolic manifestations involving adipose tissue and the liver. Bergamot, due to its antioxidant and anti-inflammatory properties, has been used to treat metabolic disorders...

  • Review
  • Open Access
11 Citations
5,287 Views
21 Pages

14 February 2025

Conventionally, drug-induced liver injury (DILI) exists in two types: idiosyncratic and intrinsic. Both types are classified as non-immune disorders, thereby ignoring that some iDILI cases may have an immune or autoimmune background that requires a d...

  • Review
  • Open Access
11 Citations
9,204 Views
15 Pages

2 November 2022

Chronic liver diseases (CLDs) that lead to hepatic fibrosis, cirrhosis, and/or hepatocellular carcinoma (HCC) have become a major cause of illness and death worldwide. The main causative factors for CLDs are chronic viral infections, excessive alcoho...

(This article belongs to the Topic Liver Fibrosis and Cirrhosis)
  • Review
  • Open Access
11 Citations
14,689 Views
20 Pages

Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging Therapies

  • Jacob Beiriger,
  • Kashyap Chauhan,
  • Adnan Khan,
  • Taha Shahzad and ,
  • Natalia Salinas Parra,
  • Peter Zhang,
  • Sarah Chen,
  • Anh Nguyen,
  • Brian Yan and
  • Dina Halegoua-DeMarzio
  • + 6 authors+ 1 author

7 November 2023

This paper provides a comprehensive review of the current understanding of non-alcoholic fatty liver disease (NAFLD) and its progression to non-alcoholic steatohepatitis (NASH), focusing on key factors influencing its pathogenesis and emerging therap...

  • Review
  • Open Access
10 Citations
5,564 Views
11 Pages

Targeting Autophagy for Acetaminophen-Induced Liver Injury: An Update

  • Kaitlyn Hinz,
  • Mengwei Niu,
  • Hong-Min Ni and
  • Wen-Xing Ding

14 August 2024

Acetaminophen (APAP) overdose can induce hepatocyte necrosis and acute liver failure in experimental rodents and humans. APAP is mainly metabolized via hepatic cytochrome P450 enzymes to generate the highly reactive metabolite N-acetyl-p-benzoquinone...

(This article belongs to the Special Issue Recent Advances in Acetaminophen Hepatotoxicity)
  • Review
  • Open Access
10 Citations
7,984 Views
20 Pages

Support Needs and Coping Strategies in Non-Alcoholic Fatty Liver Disease (NAFLD): A Multidisciplinary Approach to Potential Unmet Challenges beyond Pharmacological Treatment

  • Sue Shea,
  • Christos Lionis,
  • Lou Atkinson,
  • Chris Kite and ,
  • Lukasz Lagojda,
  • Surinderjeet S. Chaggar,
  • Ioannis Kyrou and
  • Harpal S. Randeva
  • + 3 authors+ 0 author

23 December 2022

Non-alcoholic fatty liver disease (NAFLD) is the most frequently occurring chronic liver disease, affecting approximately 25–30% of the adult general population worldwide. NAFLD reflects excess hepatic accumulation of fat in the absence of incr...

XFacebookLinkedIn
Livers - ISSN 2673-4389